Efficacy and morbidity of daunomycin (NSC-82151) added to vincristine (NSC-67574) and prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia
Verzosa, M.; Fite, A.
Cancer ChemoTherapy Reports 55(1): 79-82
1971
ISSN/ISBN: 0069-0112 PMID: 5287341 Document Number: 35712
Document emailed within 1 workday
Related Documents
Pratt, C.B.; Roberts, D.; Shanks, E.; Warmath, E.L.; Jackson, R. 1973: Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia Cancer Research 33(9): 2020-2025Anderson, J.; Krivit, W.; Chilcote, R.; Pyesmany, A.; Chard, R.; Hammond, D. 1981: Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase IIi trial Cancer Treatment Reports 65(11-12): 1015-1019
Musgrave, S.; Dickerman, J.D.; Land, V.J. 1986: Second or subsequent remission with a disease-free survival of 5 years or longer in acute lymphocytic leukemia of childhood: results of a national survey Pediatrics 77(5): 765-769
Hafiz, M.G.; Mannan, M.A. 2008: Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission Mymensingh Medical Journal: Mmj 17(2 Suppl): S46-S51
Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Leone, G.; Pagano, L.; Marra, R.; Landolfi, R.; Cudillo, L.; Storti, S.; Mango, G.; Alfano, G.; D'Onofrio, G. 1987: Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia Cancer Treatment Reports 71(7-8): 751-753
Avilés-Miranda, A.; Monroy-Arellano, L.M.; Conte-Lanza, G.; Morales-Polanco, M.R.; Pizzuto-Chávez, J. 1980: Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult Gaceta Medica de Mexico 116(8): 359-364
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Whitecar, J.P.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; Hart, J.S. 1972: Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults Cancer ChemoTherapy Reports 56(4): 543-550
Yoshikawa, H.; Sao, H.; Tahara, T.; Akao, Y.; Yoshikawa, S. 1984: A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 515-520
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Bassan, R.; Barbui, T. 1995: Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica 80(1): 82-90
Michel, K.; Hubbel, C.; Dock, N.L.; Davey, F.R. 1981: Correlation of HLA-DRw3 with childhood acute lymphocytic leukemia Archives of Pathology and Laboratory Medicine 105(10): 560
Laila, R.; Islam, A.; Bhuiyan, M.M. 2016: Incidence of Hyperglycemia during Induction of Remission Phase of Pediatric Acute Lymphoblastic Leukemia Mymensingh Medical Journal: Mmj 25(4): 730-735
Saito, M.; Ino, T.; Shigemura, H.; Shimizu, S.; Matsui, T.; Ono, Y.; Nakamura, K.; Okamoto, M.; Takada, T.; Imura, H. 1985: Clinical evaluation of cases of remission induction failure in acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 554-560
Bowman, W.P. 1981: Childhood acute lymphocytic leukemia: progress and problems in treatment Canadian Medical Association Journal 124(2): 129-142
Aur, R.J.; Simone, J.V.; Verzosa, M.S.; Hustu, H.O.; Barker, L.F.; Pinkel, D.P. 1975: Comparison of four schedules of chemotherapy during remission of acute lymphoblastic leukemia in childhood Sangre 20(3): 237-244
Smith, F.O.; Raskind, W.H.; Waldron, P.; Steinmann, L.J.; Matsushita, M.; Singer, J.W.; Lampkin, B.C.; Woods, W.G.; Lange, B.J.; Hammond, G.D. 1993: Clonal remission in childhood acute myeloid leukemia is an infrequent event Leukemia 7(7): 929-932
Lorenzo, J.I.; Sanz, M.A.; Martín-Aragonés, G.; Rafecas, F.J.; Martínez, J.A.; Sanz, G.; Gomis, F. 1988: Prognostic factors and predictive models of the different causes of failure in te induction of remission in acute nonlymphoblastic leukemia Medicina Clinica 90(4): 151-155